Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2020

01-09-2020 | Original Article

Comparison of Legionella K-set® and BinaxNOW® Legionella for diagnosing Legionnaires’ disease on concentrated urine samples

Authors: Aubin Souche, Ghislaine Descours, Anne-Gaëlle Ranc, Gérard Lina, Sophie Jarraud, Laetitia Beraud

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2020

Login to get access

Abstract

Detection of Legionella pneumophila serogroup 1 urinary antigens is the most widely used technique for the diagnosis of Legionnaires’ disease (LD). The aim of this study was to evaluate the performance of the Legionella K-set® immunochromatographic test, in comparison with the BinaxNOW® Legionella urinary antigen card (UAC) on concentrated urine samples (US). A total of 250 concentrated US including 200 prospective US sent to the laboratory for urinary antigens’ testing and 50 frozen US from patients with confirmed LD were tested. Positive US were retested after boiling (5 min, 100 °C). Each US leading to discordant results between the two tests was further tested using Binax™ Legionella EIA. Then, 10 additional positive non-concentrated US were tested using both tests. On concentrated US, Legionella K-set® test showed concordant results with that of BinaxNOW® Legionella. All negative US with BinaxNOW® were negative with Legionella K-set® test. For the 50 frozen US, all were positive with BinaxNOW® and 49 were positive with Legionella K-set®, all confirmed after boiling except 3 US which led to uninterpretable results with Legionella K-set®, due to a migration defect. Three of the 10 additional positive non-concentrated US were found negative with Legionella K-set® and only 1 US remained negative after concentration. All these positive non-concentrated US were positive with BinaxNOW® Legionella. The performance of the Legionella K-set® test is comparable to that of BinaxNOW® Legionella UAC, if performed on concentrated US.
Literature
5.
go back to reference Heath C, Grove D, Looke D (1996) Delay in appropriate therapy of Legionella pneumonia associated with increased mortality. Eur J Clin Microbiol Infect Dis 4(15):286–290CrossRef Heath C, Grove D, Looke D (1996) Delay in appropriate therapy of Legionella pneumonia associated with increased mortality. Eur J Clin Microbiol Infect Dis 4(15):286–290CrossRef
6.
go back to reference Beauté J, Zucs P, De Jong B, on behalf of the European Legionnaires’ Disease Surveillance Network (2013) Legionnaires’ disease in Europe, 2009–2010. Euro Surveill 18(10):pll-20417CrossRef Beauté J, Zucs P, De Jong B, on behalf of the European Legionnaires’ Disease Surveillance Network (2013) Legionnaires’ disease in Europe, 2009–2010. Euro Surveill 18(10):pll-20417CrossRef
8.
go back to reference Congestrì F, Crepaldi E, Gagliardi M, Pedna MF, Sambri V, Onderdonk AB (2016) Comparative evaluation of the novel bioNexia Legionella test with the BinaxNOW Legionella card assay and the Sofia Legionella FIA assay for detection of Legionella pneumophila (serogroup 1) antigen in urine samples. J Clin Microbiol 54(4):1164–1166. https://doi.org/10.1128/JCM.03340-15CrossRefPubMedPubMedCentral Congestrì F, Crepaldi E, Gagliardi M, Pedna MF, Sambri V, Onderdonk AB (2016) Comparative evaluation of the novel bioNexia Legionella test with the BinaxNOW Legionella card assay and the Sofia Legionella FIA assay for detection of Legionella pneumophila (serogroup 1) antigen in urine samples. J Clin Microbiol 54(4):1164–1166. https://​doi.​org/​10.​1128/​JCM.​03340-15CrossRefPubMedPubMedCentral
17.
go back to reference Williams A, Lever MS (1995) Characterisation of Legionella pneumophila antigen in urine of Guinea pigs and humans with Legionnaires’ disease. J Inf Secur 30(1):13–16 Williams A, Lever MS (1995) Characterisation of Legionella pneumophila antigen in urine of Guinea pigs and humans with Legionnaires’ disease. J Inf Secur 30(1):13–16
20.
go back to reference Muñoz M, Martínez Toldos M, Yaqüe G, Seqovia M (2009) Evaluation of three immunochromatographic assays for detection of Legionella pneumophila serogroup 1 antigen in urine samples. Rev Esp Quimioter 4(22):207–209 Muñoz M, Martínez Toldos M, Yaqüe G, Seqovia M (2009) Evaluation of three immunochromatographic assays for detection of Legionella pneumophila serogroup 1 antigen in urine samples. Rev Esp Quimioter 4(22):207–209
22.
go back to reference Dominguez JA et al (1998) Comparison of the Binax Legionella urinary antigen enzyme immunoassay (EIA) with the biotest Legionella Urin antigen EIA for detection of Legionella antigen in both concentrated and nonconcentrated urine samples. J Clin Microbiol 36(9):2718–2722CrossRef Dominguez JA et al (1998) Comparison of the Binax Legionella urinary antigen enzyme immunoassay (EIA) with the biotest Legionella Urin antigen EIA for detection of Legionella antigen in both concentrated and nonconcentrated urine samples. J Clin Microbiol 36(9):2718–2722CrossRef
23.
go back to reference Guerrero C, Toldos CM, Yagüe G, Ramírez C, Rodríguez T, Segovia M (2004) Comparison of diagnostic sensitivities of three assays (Bartels enzyme immunoassay [EIA], Biotest EIA, and Binax NOW immunochromatographic test) for detection of Legionella pneumophila serogroup 1 antigen in urine. J Clin Microbiol 42(1):467–468CrossRef Guerrero C, Toldos CM, Yagüe G, Ramírez C, Rodríguez T, Segovia M (2004) Comparison of diagnostic sensitivities of three assays (Bartels enzyme immunoassay [EIA], Biotest EIA, and Binax NOW immunochromatographic test) for detection of Legionella pneumophila serogroup 1 antigen in urine. J Clin Microbiol 42(1):467–468CrossRef
24.
go back to reference Dominguez JA et al (1996) Detection of Legionella pneumophila serogroup 1 antigen in nonconcentrated urine and urine concentrated by selective ultrafiltration. J Clin Microbiol 34(9):2334–2336CrossRef Dominguez JA et al (1996) Detection of Legionella pneumophila serogroup 1 antigen in nonconcentrated urine and urine concentrated by selective ultrafiltration. J Clin Microbiol 34(9):2334–2336CrossRef
26.
go back to reference Beraud L et al Performances of the BinaxNOW® Legionella urinary antigen rapid test in conjunction with the Alere™ Reader., Poster 11 Present. 9th Int. Conf. Legion. Rome 26th–30th Sept. 2017 Beraud L et al Performances of the BinaxNOW® Legionella urinary antigen rapid test in conjunction with the Alere™ Reader., Poster 11 Present. 9th Int. Conf. Legion. Rome 26th–30th Sept. 2017
27.
go back to reference Deforges L, Legrand P, Tankovic J, Brun-Buisson C, Lang P, Soussy C-J (1999) Case of false-positive results of the urinary antigen test for Legionella pneumophila. Clin Infect Dis 29(4):953–954CrossRef Deforges L, Legrand P, Tankovic J, Brun-Buisson C, Lang P, Soussy C-J (1999) Case of false-positive results of the urinary antigen test for Legionella pneumophila. Clin Infect Dis 29(4):953–954CrossRef
28.
go back to reference Doskeland SO, Berdal BP (1980) Bacterial antigen detection in body fluids: methods for rapid antigen concentration and reduction of nonspecific reactions. J Clin Microbiol 11(4):380–384CrossRef Doskeland SO, Berdal BP (1980) Bacterial antigen detection in body fluids: methods for rapid antigen concentration and reduction of nonspecific reactions. J Clin Microbiol 11(4):380–384CrossRef
Metadata
Title
Comparison of Legionella K-set® and BinaxNOW® Legionella for diagnosing Legionnaires’ disease on concentrated urine samples
Authors
Aubin Souche
Ghislaine Descours
Anne-Gaëlle Ranc
Gérard Lina
Sophie Jarraud
Laetitia Beraud
Publication date
01-09-2020
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2020
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-020-03892-x

Other articles of this Issue 9/2020

European Journal of Clinical Microbiology & Infectious Diseases 9/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine